Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation
Active, not recruiting · NCT04531046 · Registry updated 2026-03-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Axi-Cel as a 2nd Line Therapy in Patients With Relapsed/Refractory Aggressive B Lymphoma Ineligible to Autologous Stem Cell Transplantation | B-Cell Lymphoma Refractory; B-cell Lymphoma Recurrent | Active, not recruiting | Phase 2 | 2026-03-27 | NCT04531046 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The Lymphoma Academic Research Organisation | 20 |
16 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| APHP - Hôpital Henri Mondor | Créteil | France | 4 |
| APHP - Hôpital Saint Louis | Paris | France | 1 |
| Centre Hospitalier Lyon Sud | Pierre-Bénite | France | 51 |
| CH Liège | Liège | Belgium | 1 |
| CHU Brabois | Vandœuvre-lès-Nancy | France | 5 |
| CHU Clermont Ferrand - Hôpital Estaing | Clermont-Ferrand | France | 1 |
| CHU de Bordeaux - Hôpital Haut Lévêque | Bordeaux | France | 2 |
| CHU de Dijon - Hôpital le Bocage | Dijon | France | 2 |
| CHU de Nantes - Hôtel Dieu | Nantes | France | 4 |
| CHU de Rennes - Hôpital de Pontchaillou | Rennes | France | 1 |
| Hopital La Pitié Salpétriere | Paris | France | 1 |
| Hôpital Claude Huriez | Lille | France | 6 |
| Hôpital Saint Antoine | Paris | France | 21 |
| Hôpital Saint Eloi | Montpellier | France | 2 |
| Institut de Cancérologie Gustave Roussy | Villejuif | France | 2 |
| IUCT Oncopole | Toulouse | France | 7 |